• Grogan, S., & Preuss, C. V. (2023). Pharmacokinetics. National Library of Medicine. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK557744/

​

• Emileyi, J. (2023, May 30). The pivotal role of drug development in the improvement of health care system. Pulsus. Retrieved from https://www.jbclinpharm.org/articles/the-pivotal-role-of-drug-development-in-the-improvement-of-health-care-system-12176.html#:~:text=Drug%20discovery%20plays%20a%20key,and%20driving%20innovation%20in%20healthcare 

​

• Wagner, J. G. (1977). The history of pharmacokinetics. Drug Intelligence & Clinical Pharmacy. Retrieved from https://www.sciencedirect.com/sdfe/pdf/download/eid/1-s2.0-0163725881900978/first-page-pdf 

​

• Paalzow, L. K. (1995). Torsten Teorell, the father of pharmacokinetics. Upsala Journal of Medical Sciences, 100(1), 41–46. Retrieved from https://doi.org/10.3109/03009739509178895

​

• Talevi, A., & Bellera, C. L. (2022). Two-Compartment pharmacokinetic model. In Springer eBooks (pp. 1167–1174). Retrieved from https://doi.org/10.1007/978-3-030-84860-6_59 

​

• Macheras, P., & Tsekouras, A. A. (2023). From Bateman (1910) to Dost (1953). In Springer eBooks (pp. 3–8). Retrieved from https://doi.org/10.1007/978-3-031-20025-0_1 

​

• Shafer, Steven L. (2020). The evolution of pharmacokinetics. British Journal of Anaesthesia. Retrieved from https://www.bjanaesthesia.org/article/S0007-0912(20)30151-3/fulltext#keywords 

​

• Ma, G., Pharmacometrics Group, Department of Pharmacology & Clinical Pharmacology, & The University of Auckland. (2020). Non-Linear elimination. Retrieved from https://clinpharmacol.fmhs.auckland.ac.nz/docs/nonlinear-pk_gm.pdf 

​

• Gyimesi, G., & Hediger, M. A. (2023). Transporter-Mediated Drug Delivery. Molecules, 28(3), 1151. Retrieved from https://doi.org/10.3390/molecules28031151 

​

• Hepatic clearance – pharmacokinetics. (n.d.-b). Retrieved from https://sepia2.unil.ch/pharmacology/parameters/hepaticclearance/#:~:text=Hepatic%20clearance%20quantifies%20the%20loss,of%20liver%20enzymes%20and%20transporters.

​

• Lai, Y., Chu, X., Di, L., Gao, W., Guo, Y., Liu, X., Lu, C., Mao, J., Shen, H., Tang, H., Xia, C. Q., Zhang, L., & Ding, X. (2022). Recent advances in the translation of drug metabolism and pharmacokinetics science for drug discovery and development. National Library of Medicine. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC9214059/ 

​

• Santiagola. (2022, November 22). Introduction to antibody-drug conjugates (ADCs). Santiago Lab. Retrieved from https://www.santiago-lab.com/introduction-to-antibody-drug-conjugates-adcs/ 

​

• Rani, P., & Naidu, M. (2008). Phase 0 - Microdosing strategy in clinical trials. National Library of Medicine, Indian Journal of Pharmacology. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC3025138/ 

​

• Johnson, G. (2024, May 1). Using microdosing to enhance development. GEN - Genetic Engineering and Biotechnology News. Retrieved from https://www.genengnews.com/insights/using-microdosing-to-enhance-development/ 

​

• Cramer, S. P., Vestergaard, M. B., Lindberg, U., & Larsson, H. B. (2020). Physical and physiological principles of perfusion and permeability. In Advances in magnetic resonance technology and applications (pp. 269–294). Retrieved from https://doi.org/10.1016/b978-0-12-817057-1.00013-5 

​

• ditki (2019, August 14). Volume of distribution. Ditki Medical & Biological Sciences. Retrieved from https://ditki.com/course/pharmacology/glossary/pharmacology/volume-of-distribution 

​

• Genomind (2022). Introduction to Pharmacokinetics: Four Steps in a Drug’s Journey Through the Body. Genomind - Your Medication Management Partner. Retrieved from https://genomind.com/providers/introduction-to-pharmacokinetics-four-steps-in-a-drugs-journey-through-the-body/ 
   

• EUPATI Toolbox (n.d.). Pharmacokinetics - EUPATI toolbox. EUPATI Toolbox. Retrieved from https://toolbox.eupati.eu/glossary/pharmacokinetics/ 

​

• Hartmanshenn, C., Scherholz, M., & Androulakis, I. P. (2016). Physiologically-based pharmacokinetic models: Approaches for enabling personalized medicine. National Library of Medicine. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC5204363/#:~:text=Physiologically%2Dbased%20Pharmacokinetic%20(PBPK),predict%20the%20distribution%20of%20pharmacokinetic 

​

• Tjorvi E. Perry, Charles D. Collard  (2013). Pharmacology and Physiology for Anesthesia. ScienceDirect. Retrieved from https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/cytochrome-p450-family-1#:~:text=Cytochrome%20P450%20(CYP)%20is%20one,molecules%20for%20its%20future%20elimination. 

​

• Onbeat (2022). Genes and Medications– An Overview of Pharmacogenomics. Clinical Conversations. Retrieved from https://www.thermofisher.com/blog/clinical-conversations/genes-medications-overview-pharmacogenomics/#:~:text=Mutations%20can%20affect%20drug%20metabolism,or%20even%20harmful%20to%20patients. 

​

• Darwich, A. S., Polasek, T. M., Aronson, J. K., Ogungbenro, K., Wright, D. F. B., Achour, B., Reny, J.-L., Daali, Y., Eiermann, B., Cook, J., Lesko, L., McLachlan, A. J., & Rostami-Hodjegan, A. (2021). Model-Informed Precision Dosing: Background, Requirements, Validation, Implementation, and Forward Trajectory of Individualizing Drug Therapy. Annual Review of Pharmacology and Toxicology. Retrieved from https://www.annualreviews.org/content/journals/10.1146/annurev-pharmtox-033020-113257 

​

• Munir Pirmohamed, B.Kevin Park (2001). Genetic susceptibility to adverse drug reactions. ScienceDirect. Retrieved from https://www.sciencedirect.com/science/article/abs/pii/S016561470001717X 

​

• Julesbick (2024). The Synergy of Pharmacogenomics and Pharmacokinetics in Drug Development: Unraveling the code for Precision Medicine. Incite Health. Retrieved from https://incitehealth.com/synergy-of-pharmacogenomics-and-pharmacokinetics-in-drug-development/ 

​

• Kamali, F., & Wynne, H. (2010). Pharmacogenetics of Warfarin. Annual Review of Medicine, 61(1), 63–75. Retrieved from https://doi.org/10.1146/annurev.med.070808.170037 

​

• Lee, M. T. M., & Klein, T. E. (2013). Pharmacogenetics of warfarin: challenges and opportunities. Journal of Human Genetics, 58(6), 334–338. Retrieved from https://doi.org/10.1038/jhg.2013.40 

​

• Wadelius, M., & Pirmohamed, M. (2006). Pharmacogenetics of warfarin: current status and future challenges. The Pharmacogenomics Journal, 7(2), 99–111. Retrieved from https://doi.org/10.1038/sj.tpj.6500417 

​

• Frére, C., Cuisset, T., Gaborit, B., Alessi, M., & Hulot, J. (2009). The CYP2C19*17 allele is associated with better platelet response to clopidogrel in patients admitted for non-ST acute coronary syndrome. Journal of Thrombosis and Haemostasis, 7(8), 1409–1411. Retrieved from https://doi.org/10.1111/j.1538-7836.2009.03500.x 

​

• Gasche, Y., Daali, Y., Fathi, M., Chiappe, A., Cottini, S., Dayer, P., & Desmeules, J. (2004). Codeine Intoxication Associated with Ultrarapid CYP2D6 Metabolism. New England Journal of Medicine, 351(27), 2827–2831. Retrieved from https://doi.org/10.1056/nejmoa041888 

​

• McNally, K., Cotton, R., & Loizou, G. D. (2011). A workflow for global sensitivity analysis of PBPK models. Frontiers in Pharmacology, 2. Retrieved from https://doi.org/10.3389/fphar.2011.00031 

​

• Sun, Z., Zhao, N., Zhao, X., Wang, Z., Liu, Z., & Cui, Y. (2024). Application of physiologically based pharmacokinetic modeling of novel drugs approved by the U.S. food and drug administration. European Journal of Pharmaceutical Sciences, 200, 106838. Retrieved from  https://doi.org/10.1016/j.ejps.2024.106838

​

• Sawers, P. (2019). Verisim Life uses AI-powered biosimulations to replace animal drug testing. VentureBeat. Retrieved from https://venturebeat.com/ai/verisim-life-uses-ai-powered-biosimulations-to-replace-animal-drug-testing/

​

​

​